BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20149075)

  • 1. Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism.
    White RH; Murin S; Wun T; Danielsen B
    J Thromb Haemost; 2010 May; 8(5):987-97. PubMed ID: 20149075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
    Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?
    Chua CC; Lim HY; Tacey M; Nandurkar H; Ho P
    Eur J Haematol; 2017 Jul; 99(1):18-26. PubMed ID: 28321922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.
    Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J
    J Thromb Thrombolysis; 2018 Oct; 46(3):339-345. PubMed ID: 29881958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode.
    Farren-Dai L; Carrier M; Kovacs J; Rodger M; Kovacs MJ; Le Gal G;
    J Thromb Haemost; 2017 Oct; 15(10):1977-1980. PubMed ID: 28795538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
    Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
    Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.
    Ageno W; Farjat A; Haas S; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
    Res Pract Thromb Haemost; 2021 Feb; 5(2):326-341. PubMed ID: 33733032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism.
    Nemeth B; Lijfering WM; Nelissen RGHH; Schipper IB; Rosendaal FR; le Cessie S; Cannegieter SC
    JAMA Netw Open; 2019 May; 2(5):e193690. PubMed ID: 31074822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients.
    Betancourt MT; Rodger MA
    Acta Chir Belg; 2007; 107(6):636-40. PubMed ID: 18274176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head.
    Sung PH; Chiang HJ; Yang YH; Chiang JY; Chen CJ; Yip HK; Lee MS
    Int Orthop; 2018 Jul; 42(7):1469-1478. PubMed ID: 29541810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
    Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.